Euless, TX, United States of America

David C Foster


Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 28(Granted Patents)


Location History:

  • La Place, LA (US) (1996)
  • Euless, TX (US) (2022)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: David C Foster: Innovator in Therapeutic Proteins

Introduction

David C Foster is a notable inventor based in Euless, Texas, with a focus on developing innovative therapeutic proteins. He holds three patents that contribute significantly to the field of medicine, particularly in the area of immune modulation.

Latest Patents

Foster's latest patents include the invention of single-chain TNF receptor 2 agonist fusion proteins. This invention provides for a fusion protein between a single chain TNFR2 Selective Agonist protein and a dimerization domain, such as an IgGFc protein. The single chain TNFR2 Selective Agonist moiety offers therapeutic activity by selectively activating the TNFR2 form of the TNF-α receptor, thus selectively stimulating Tregs and/or increasing myelin deposition.

Career Highlights

Throughout his career, David C Foster has worked with various companies, including Relinia, Inc. His contributions to the field have been recognized through his innovative patents and research.

Collaborations

Foster has collaborated with notable professionals in his field, including Lutz B Giebel and Leonard G Presta. Their combined expertise has likely enhanced the development of his inventions.

Conclusion

David C Foster's work in the development of therapeutic proteins showcases his commitment to advancing medical science. His patents reflect significant innovations that may lead to improved treatments for various conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…